High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University and other 11 well-known
hospitals in China. In order to report the efficacy and safety of high-dose dexamethasone
compared to conventional dose prednisone for the first-line treatment of adults with primary
immune thrombocytopenia(ITP).
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Collaborators:
Anhui Provincial Hospital Chinese Academy of Medical Sciences Peking Union Medical College Hospital People's Hospital of Xinjiang Uygur Autonomous Region Ruijin Hospital Second Hospital of Shanxi Medical University Shandong University of Traditional Chinese Medicine Shenzhen Second People's Hospital Tongji Hospital Wuhan Union Hospital, China Xinjiang Uygur Autonomous Region People's Hospital Zhejiang Provincial Hospital of TCM